These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8969980)

  • 21. Bioequivalence of single and multiple doses of venlafaxine extended-release tablets and capsules in the fasted and fed states: four open-label, randomized crossover trials in healthy volunteers.
    Wright CW; Aikman MS; Werts E; Seabolt J; Haeusler JM
    Clin Ther; 2009 Nov; 31(11):2722-34. PubMed ID: 20110014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of the random-effects pattern mixture model with last-observation-carried-forward (LOCF) analysis in longitudinal clinical trials with dropouts.
    Siddiqui O; Ali MW
    J Biopharm Stat; 1998 Nov; 8(4):545-63. PubMed ID: 9855033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Venlafaxine in the treatment of children and adolescents with major depression.
    Mandoki MW; Tapia MR; Tapia MA; Sumner GS; Parker JL
    Psychopharmacol Bull; 1997; 33(1):149-54. PubMed ID: 9133767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-level models for repeated measurement data: application to quality of life data in clinical trials.
    Beacon HJ; Thompson SG
    Stat Med; 1996 Dec; 15(24):2717-32. PubMed ID: 8981682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction between ECT and venlafaxine.
    Jha A; Tomar R
    Int J Geriatr Psychiatry; 2002 Oct; 17(10):979-80. PubMed ID: 12325062
    [No Abstract]   [Full Text] [Related]  

  • 26. Venlafaxine XR in the treatment of anxiety.
    Hackett D
    Acta Psychiatr Scand Suppl; 2000; (406):30-5. PubMed ID: 11131468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study.
    Davidson J; Rothbaum BO; Tucker P; Asnis G; Benattia I; Musgnung JJ
    J Clin Psychopharmacol; 2006 Jun; 26(3):259-67. PubMed ID: 16702890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bruxism possibly induced by venlafaxine.
    Alonso-Navarro H; Martín-Prieto M; Ruiz-Ezquerro JJ; Jiménez-Jiménez FJ
    Clin Neuropharmacol; 2009; 32(2):111-2. PubMed ID: 19512964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Handling missing data issues in clinical trials for rheumatic diseases.
    Wong WK; Boscardin WJ; Postlethwaite AE; Furst DE
    Contemp Clin Trials; 2011 Jan; 32(1):1-9. PubMed ID: 20840873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing venlafaxine extended release and fluoxetine for preventing the recurrence of major depression: results from the PREVENT study.
    Thase ME; Gelenberg A; Kornstein SG; Kocsis JH; Trivedi MH; Ninan P; Li T; Pedersen R; Keller M
    J Psychiatr Res; 2011 Mar; 45(3):412-20. PubMed ID: 20801464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression.
    Shrivastava RK; Cohn C; Crowder J; Davidson J; Dunner D; Feighner J; Kiev A; Patrick R
    J Clin Psychopharmacol; 1994 Oct; 14(5):322-9. PubMed ID: 7806687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extended-release venlafaxine in relapse prevention for patients with major depressive disorder.
    Simon JS; Aguiar LM; Kunz NR; Lei D
    J Psychiatr Res; 2004; 38(3):249-57. PubMed ID: 15003430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using meta-regression in performing indirect-comparisons: comparing escitalopram with venlafaxine XR.
    Eckert L; Falissard B
    Curr Med Res Opin; 2006 Nov; 22(11):2313-21. PubMed ID: 17076991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression.
    Luthringer R; Toussaint M; Schaltenbrand N; Bailey P; Danjou PH; Hackett D; Guichoux JY; Macher JP
    Psychopharmacol Bull; 1996; 32(4):637-46. PubMed ID: 8993085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic options for treating major depression, and the role of venlafaxine.
    Scott MA; Shelton PS; Gattis W
    Pharmacotherapy; 1996; 16(3):352-65. PubMed ID: 8726593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of venlafaxine in children and adolescents: a review of current literature.
    Weller EB; Weller RA; Davis GP
    Depress Anxiety; 2000; 12 Suppl 1():85-9. PubMed ID: 11098420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How to collect, check, and analyze data from clinical trials and be proud of it!
    Cauquil J; Laquais B; Riviere L
    Medinfo; 1995; 8 Pt 2():1095-6. PubMed ID: 8591378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of program success for programs with multiple trials in binary outcomes.
    Wang M; Liu GF; Schindler J
    Pharm Stat; 2015; 14(3):172-9. PubMed ID: 25645143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concerns with analysis of correlated eye data.
    Gilger BC
    Vet Ophthalmol; 2011 May; 14(3):214. PubMed ID: 21521448
    [No Abstract]   [Full Text] [Related]  

  • 40. Review of guidelines and literature for handling missing data in longitudinal clinical trials with a case study.
    Liu M; Wei L; Zhang J
    Pharm Stat; 2006; 5(1):7-18. PubMed ID: 17080924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.